Literature DB >> 8188358

Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

P Ray1, N Sahoo, B Singh, F A Kironde.   

Abstract

We demonstrated that antibodies in the serum of BALB/c mice convalescent from Plasmodium yoelii infection inhibit the in vitro growth of Plasmodium falciparum. Blood stage P. falciparum antigens that cross-react with the convalescent-phase mouse serum antibodies were identified and partially characterized. Convalescent-phase mouse serum immunoglobulin G (IgG) reacted with P. falciparum lysates at up to a 1:15,000 dilution of the immune sera and bound to P. falciparum-parasitized erythrocytes at up to a 1:5,000 dilution of the sera. The cross-reactive moieties of antigens in parasite lysates were resistant to oxidation by periodate but sensitive to trypsinization. About 15 polypeptides (M(r)s of 15,000 to 110,000) of P. falciparum blood stages were recognized by the convalescent-phase mouse anti-P. yoelii sera; many of these antigens were metabolically 35S labeled and specifically immunoprecipitated. Also, virtually all of the cross-reactive antigens were recognized by human malaria-immune sera. The anti-P. yoelii serum antibodies bound, with high affinity, to at least five of the cross-reactive antigens (M(r)s of 107,000, 84,000, 53,000, 36,000, and 30,000). By phase separation in Triton X-114, eight interspecies cross-reactive antigens (M(r)s of 84,000, 76,000, 51,000, 31,000, 29,000, 28,000, 23,000, and 22,000) were found to be integral membrane proteins. Convalescent-phase mouse serum IgG strongly inhibited the differentiation of P. falciparum from schizonts to rings; 75 micrograms of IgG per ml caused 80% inhibition of release of merozoites and their invasion into erythrocytes. On the other hand, the anti-P. yoelii serum antibodies also inhibited intracellular development of P. falciparum from rings to schizonts; 25 micrograms of IgG per ml caused 50% inhibition. Inhibition of P. falciparum growth by anti-P. yoelii serum IgG suggests that some of the interspecies cross-reactive antigens contain important conserved epitopes and induce protective antibodies against P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188358      PMCID: PMC186518          DOI: 10.1128/iai.62.6.2354-2361.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites.

Authors:  G Cowan; S Krishna; A Crisanti; K Robson
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

5.  Cloning of cDNAS that code for Plasmodium chabaudi antigens of the erythrocytic forms and cross-hybridize with P. falciparum.

Authors:  J Franco Da Silveira; L Sibilli; E Brunet; O Mercereau-Puijalon
Journal:  Mol Biochem Parasitol       Date:  1984-04       Impact factor: 1.759

6.  Plasmodium falciparum: assay in vitro for inhibitors of merozoite penetration of erythrocytes.

Authors:  M M Weiss; J D Oppenheim; J P Vanderberg
Journal:  Exp Parasitol       Date:  1981-06       Impact factor: 2.011

7.  Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum.

Authors:  J A Smythe; M G Peterson; R L Coppel; A J Saul; D J Kemp; R F Anders
Journal:  Mol Biochem Parasitol       Date:  1990-03       Impact factor: 1.759

Review 8.  T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.

Authors:  E H Nardin; R S Nussenzweig
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum.

Authors:  A A Holder; R R Freeman; C I Newbold
Journal:  Mol Biochem Parasitol       Date:  1983-11       Impact factor: 1.759

10.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

Authors:  A A Holder; R R Freeman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more
  7 in total

1.  Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.

Authors:  K Brahimi; E Badell; J P Sauzet; L BenMohamed; P Daubersies; C Guérin-Marchand; G Snounou; P Druilhe
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  [Humoral response to Plasmodium falciparum antigenic peptides (MSP1, MSP2, and SR-11.1) in subjects living in endemic areas].

Authors:  Yacouba Sourabié; Yétéma Dieudonné Yonli; Francis Fumoux; Yves Traoré
Journal:  Pan Afr Med J       Date:  2022-03-28

3.  Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

Authors:  Preeyaporn Monatrakul; Mathirut Mungthin; Arjen M Dondorp; Srivicha Krudsood; Rachanee Udomsangpetch; Polrat Wilairatana; Nicholas J White; Kesinee Chotivanich
Journal:  Malar J       Date:  2010-11-16       Impact factor: 2.979

4.  High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.

Authors:  Sreenivasulu B Reddy; Robin F Anders; James G Beeson; Anna Färnert; Fred Kironde; Sharon Kühlman Berenzon; Mats Wahlgren; Sara Linse; Kristina E M Persson
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

5.  Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria.

Authors:  Mark Kaddumukasa; Catherine Lwanira; Allan Lugaajju; Elly Katabira; Kristina E M Persson; Mats Wahlgren; Fred Kironde
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  In silico epitope mapping and experimental evaluation of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) as a malaria vaccine candidate.

Authors:  Pedro Cravo; Renato B Machado; Juliana A Leite; Taizy Leda; Rossarin Suwanarusk; Najara Bittencourt; Letusa Albrecht; Carla Judice; Stefanie C P Lopes; Marcus V G Lacerda; Marcelo U Ferreira; Irene S Soares; Yun Shan Goh; Daniel Y Bargieri; François Nosten; Bruce Russell; Laurent Rénia; Fabio T M Costa
Journal:  Malar J       Date:  2018-01-10       Impact factor: 2.979

Review 7.  Liposomes for malaria management: the evolution from 1980 to 2020.

Authors:  Patrick B Memvanga; Christian I Nkanga
Journal:  Malar J       Date:  2021-07-27       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.